News Archiv
Study demonstrates that Muscular CounterPulsation - the basis of Cardiola's m.pulse® system - is "safe and efficient for improving cardiac function" non-surgically in patients with coronary artery disease (CAD)
Data presented at the Annual Congress of the Swiss Society of Cardiology
Read more...
Cardiola receives CE Mark recertification and appoints COO and VP Sales
Study published in Journal of Cardiac Surgery
Cardiola raises $2+ million from existing investors
Cash infusion is first tranche of ongoing $7+ million financing round
read more...
European Venture Summit: 2. Platz für Cardiola!